Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (”HA”) technology, announced that it has received European CE Mark approval for “ELEVESS™ Light,” the Company’s latest aesthetic product used for the treatment of fine lines and facial wrinkles.
Also tagged Aesthetic Product, Anika Therapeutics Inc, Ce Mark, Facial Wrinkles, Nasdaq
The investigational injectable filler 2.5% polyacrylamide hydrogel (AquamidR) is as effective and well tolerated as hyaluronic acid (HA, RestylaneR), for the correction of nasolabial folds, according to pivotal data released here at the 2009 American Society of Dermatologic Surgery (ASDS) meeting. In fact, the results showed the polyacrylamide hydrogel was as [...]
Also tagged American Society Of Dermatologic Surgery, Assessment Scale, Endpoint, Nasolabial Folds, Polyacrylamide Hydrogel, Promise, Six Months
Merz Pharmaceuticals, LLC, a leading specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review Merz’s premarket approval (PMA) application for Belotero(R) Balance. Belotero(R) Balance is a hyaluronic acid based monophasic gel dermal filler that utilizes a cohesive polydensified matrix (CPM(TM)) technology.
Also tagged Company Announced That, Dermal Filler, Fda, Food And Drug, Food And Drug Administration, Food And Drug Administration Fda, Llc, Matrix, Merz Pharmaceuticals, Pharmaceutical Company, Premarket Approval
